ASX:EVEFood, Beverage & TobaccoPackaged Foods & Meats
Eve Health Group Ltd
$0.016
$0.001 (5.88%)
Day Range
$0.015 – $0.017
52 Week Range
$0.015 – $0.036
Volume
556.41K
Avg Volume (10D)
144.44K
Market Cap
$5.64M
Price Chart
Market Statistics
Open$0.017
Previous Close$0.017
Day High$0.017
Day Low$0.015
52 Week High$0.036
52 Week Low$0.015
Valuation
Market Cap5.64M
Shares Outstanding352.33M
Price to Book1.21
Trading Activity
Volume556.41K
Value Traded8.52K
Bid$0.015 × 391,666
Ask$0.016 × 69,750
Performance
1 Day-5.88%
5 Day-5.88%
13 Week-44.83%
52 Week-54.29%
YTD-23.81%
Technical Indicators
RSI (14)23.76
50-Day SMA$0.021
200-Day SMA$0.024
Latest News
Biotechnology
EVE Health Group Initiates Pilot Study of Libbo Oral Soluble Film to Treat ED
EVE Health launches pilot Libbo ED study (oral soluble film), a key bioequivalence step toward regulatory approval; results expected by end-September. ASX:EVE
Biotechnology
EVE Health Appoints New CEO to Lead Company Through Next Phase of Growth
EVE Health appoints COO Ben Rohr as new CEO to drive next growth phase and accelerate commercialisation; Damian Wood shifts to regulatory/medical affairs.
Biotechnology
EVE Health Increases Capital Raising to $1.3m with $400,000 Cornerstone Investment
EVE Health Group lifts capital raise to $1.3m with $400k cornerstone, signalling reformulated-drug strategy and new science adviser amid Libbo launch.
Biotechnology
EVE Health Group Raises $0.9m to Advance Reformulated Pharmaceutical Pipeline
EVE Health Group raises $0.904m via placement to push reformulated drug delivery pipeline, accelerating IP, regulatory work and licensing talks.